Holen Sie sich die Stockscreener-App
88.99
0.63%
-0.56
Vorhandelsmarkt:
89.87
0.88
+0.99%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$89.55
Offen:
$89.555
24-Stunden-Volumen:
6.43M
Relative Volume:
1.36
Marktkapitalisierung:
$275.99B
Einnahmen:
$58.07B
Nettoeinkommen (Verlust:
$9.40B
KGV:
29.55
EPS:
3.0113
Netto-Cashflow:
$8.49B
1W Leistung:
+1.49%
1M Leistung:
+5.08%
6M Leistung:
+27.69%
1J Leistung:
+39.48%
1-Tages-Spanne:
$88.59
$90.06
1-Wochen-Bereich:
$87.62
$90.27
52-Wochen-Spanne:
$61.24
$90.27
Astrazeneca PLC Stock (AZN) Company Profile
Firmenname
Astrazeneca PLC
Sektor
Branche
Telefon
44 20 3749 5000
Adresse
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Vergleichen Sie AZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
88.99 | 277.65B | 58.07B | 9.40B | 8.49B | 3.0113 |
Astrazeneca PLC Stock (AZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Fortgesetzt | Jefferies | Buy |
| 2025-10-16 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-04-15 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2025-02-13 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-20 | Hochstufung | UBS | Sell → Neutral |
| 2024-11-06 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-09-13 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-04-16 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-02-08 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2024-01-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-01-16 | Fortgesetzt | UBS | Sell |
| 2024-01-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-12 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-04-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-09-15 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | Hochstufung | Argus | Hold → Buy |
| 2022-06-14 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-11 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-12-07 | Herabstufung | Jefferies | Buy → Hold |
| 2021-08-12 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-12 | Herabstufung | Argus | Buy → Hold |
| 2021-03-16 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-25 | Hochstufung | UBS | Neutral → Buy |
| 2021-01-15 | Eingeleitet | Deutsche Bank | Buy |
| 2020-12-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | Hochstufung | UBS | Sell → Neutral |
| 2020-11-11 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2020-09-29 | Eingeleitet | Berenberg | Buy |
| 2019-11-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-10-25 | Hochstufung | Liberum | Hold → Buy |
| 2019-04-02 | Herabstufung | UBS | Neutral → Sell |
| 2019-02-05 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-01-25 | Hochstufung | Shore Capital | Hold → Buy |
| 2018-12-11 | Fortgesetzt | Jefferies | Hold |
| 2018-10-09 | Eingeleitet | Guggenheim | Buy |
| 2018-08-16 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-19 | Hochstufung | Jefferies | Hold → Buy |
| 2018-02-06 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-05 | Bestätigt | Bernstein | Outperform |
| 2018-01-18 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-12-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-10-16 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | Hochstufung | Bernstein | Mkt Perform → Outperform |
Alle ansehen
Astrazeneca PLC Aktie (AZN) Neueste Nachrichten
AstraZeneca says Koselugo (Selumetinib) approved in the US - MarketScreener
How AstraZeneca PLC (ZEG) stock valuation compares with sector2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Burning Rock Reports Third Quarter 2025 Financial Results - GlobeNewswire Inc.
Will AstraZeneca PLC (Common Stock) (ZEGA) stock deliver compounding returnsExit Point & Daily Stock Trend Reports - newser.com
Can Precidian ETFs Trust AstraZeneca PLC stock deliver double digit returnsMarket Sentiment Review & Long-Term Capital Growth Strategies - newser.com
How AstraZeneca PLC (Common Stock) (ZEGA) stock compares with top peers2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Why AstraZeneca PLC (Common Stock) (ZEGA) stock is favored by hedge funds2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
What valuation multiples suggest for AstraZeneca PLC Depositary Receipt stock2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Will AstraZeneca PLC Depositary Receipt continue its uptrendShare Buyback & Verified Momentum Stock Ideas - newser.com
Using fundamentals and technicals on AstraZeneca PLC Depositary ReceiptEarnings Summary Report & Weekly Stock Performance Updates - newser.com
What insider trading reveals about AstraZeneca PLC Depositary Receipt stockEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Can AstraZeneca PLC (Common Stock) (ZEGA) stock surprise with quarterly resultsJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
AstraZeneca Wins FDA Approval for Selumetinib in Adult NF1 Patients - MarketScreener
AstraZeneca (AZN) Gains FDA Approval for Koselugo in Neurofibrom - GuruFocus
AstraZeneca (AZN) Gains FDA Approval for Koselugo in Adult Treat - GuruFocus
AstraZeneca trades near highs after robust financials drive institutional flows - Traders Union
Will Precidian ETFs Trust AstraZeneca PLC stock deliver compounding returnsJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Is Precidian ETFs Trust AstraZeneca PLC stock safe for risk averse investorsRecession Risk & Daily Profit Maximizing Tips - newser.com
Will AstraZeneca PLC Depositary Receipt stock benefit from sector rotationPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Is AstraZeneca PLC (ZEG) stock positioned for digital growth eraWeekly Stock Recap & Consistent Growth Equity Picks - newser.com
Is Precidian ETFs Trust AstraZeneca PLC stock a top dividend aristocrat candidateJuly 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Is AstraZeneca PLC (ZEG) stock undervalued historicallyWeekly Profit Report & Community Driven Trade Alerts - newser.com
Published on: 2025-11-18 17:18:56 - newser.com
What market sentiment indicators show for Precidian ETFs Trust AstraZeneca PLC stock2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
How AstraZeneca PLC (ZEG) stock trades under stagflationPortfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
AstraZeneca news: bullish momentum confirmed — strong support at Kijun GBX 12,949.00 - Traders Union
AstraZeneca Stock Hits Record High of $89.48 Amid Strong Q3 Performance - Somos Hermanos -
Will AstraZeneca PLC (ZEG) stock outperform small cap peersPortfolio Performance Summary & Consistent Growth Equity Picks - newser.com
Capital Group Increases Stake in AstraZeneca - TipRanks
AstraZeneca stock hits all-time high at 89.48 USD By Investing.com - Investing.com South Africa
REGAstraZeneca PLCHolding(s) in Company - TradingView
AstraZeneca stock hits all-time high at 89.48 USD - Investing.com
AstraZeneca price news: Overbought technicals warn of near-term reversal risk despite dominant buyer control - Traders Union
Has AstraZeneca PLC Depositary Receipt formed a bullish divergenceBull Run & Technical Pattern Based Signals - newser.com
Risk vs reward if holding onto AstraZeneca PLC Depositary ReceiptWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Is AstraZeneca PLC (Common Stock) (ZEGA) stock a top pick for value investors2025 Price Targets & High Return Stock Watch Alerts - newser.com
Technical signs of recovery in AstraZeneca PLC Depositary ReceiptWeekly Trading Summary & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-11-15 09:27:21 - newser.com
Using Python tools to backtest AstraZeneca PLC Depositary Receipt strategiesWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Deutsche Bank Maintains ASTRAZENECA PLC(AZNCF.US) With Sell Rating, Raises Target Price to $138.06 - 富途牛牛
Finanzdaten der Astrazeneca PLC-Aktie (AZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):